# OpenAI-backed Chai raises USD 70 million for AI-powered drug discovery

In 2025, FT reported that OpenAI-backed AI drug discovery company Chai raised USD 70 million, with investors including Menlo Ventures and Yuri Milner's DST Global Partners. It uses AI to accelerate drug discovery by analyzing large datasets to identify potential candidates.



Canonical: https://uniquebase.ai/news/10cc0bf5-69b3-40d7-8bfb-ee75446b668f
Stable identifier: 10cc0bf5-69b3-40d7-8bfb-ee75446b668f
Snapshot captured: 2026-10-18T08:51:49.337Z
English updated: 2026-10-18T08:52:14.008Z

## Connected profiles

- [Avenir Growth Capital](/institutions/avenir-growth-capital)
- [CHAI](/companies/chai)
- [DCVC](/institutions/dcvc)
- [DST Global](/institutions/dst-global)
- [Menlo Ventures](/institutions/menlo-ventures)
- [SV Angel](/institutions/sv-angel)
- [Yosemite](/institutions/yosemite)

## Sources

- https://www.ft.com/content/eeaff7a2-acc8-4a79-a564-80debdcecc1a